glp 1 direct GLP-1 Support Supplement with many recommending combining the supplement with healthy eating and hydration for optimal effects GLP-1 receptor assay: drug discovery

Important Limitations of Use : [1] Not recommended as first-line therapy for patients inadequately controlled on diet and exercise

States with no obesity GLP-1 coverage: Most remaining states including Texas, Florida, Ohio, New Jersey, and Georgia do not cover GLP-1s for obesity at all

Patients with Pre-Existing Conditions Individuals with kidney disease, gallbladder disorders, or pancreatic history face higher risks

Key challenges with GLP-1s in 2025 Adherence issues and long-term use Adherence to GLP-1s remains a significant challenge despite their proven efficacy in weight management and type 2 diabetes

This report reaffirms I-MAK's role as a leader in advancing structural reforms that improve access, equity, and affordability in the medicines system

References 1 AbtahiS.HowellE.CurrieP